GLP 1 Patches: Hype, Risks & Safer Alternatives
Are GLP 1 patches all they’re hyped up to be? Read this article to discover the truth.
- GLP 1 patches generally don’t contain actual GLP-1 medications, and instead typically contain herbal extracts and vitamins.
- The ingredients in GLP-1 patches have primarily been studied when taken orally, with little to no high-quality evidence that transdermal versions deliver comparable amounts or effects.
- Unlike prescription GLP-1 drugs, patches are sold as supplements and are not reviewed by the FDA for safety or effectiveness before being marketed, and product quality may vary by product.
- Potential risks of GLP 1 patches include skin irritation, cardiovascular effects from certain herbal ingredients, and potentially delayed access to proven treatments.
- FDA-approved options are prescription only and should be used under the guidance of a licensed healthcare provider.
This article is not intended as medical advice, nor is it intended to replace any advice given to you by a qualified healthcare professional. Always consult with your doctor to determine what’s best for you and your health.
What Are GLP 1 Patches?
In theory, the GLP-1 patch sounds great; its claim to fame is that it helps suppress hunger by simply wearing a patch for a set amount of time. But all isn’t what it seems here.
GLP-1 patches generally don’t actually contain any GLP-1 medication.
Despite the name, there is no FDA-approved GLP-1 patch containing semiglutide, tirzepatide, or any other GLP-1 receptor agonist. Instead, these patches often contain herbal extracts and vitamins, such as:
- Berberine
- Cinnamon extract
- B vitamins
- Pomegranate extract
- Green tea extract
- L-glutamine
- Garcinia cambogia
While some of these ingredients have been studied for their potential metabolic benefits, there’s limited scientific evidence indicating such effects when delivered through the skin. And the patches you see advertised online are fundamentally different from FDA-approved GLP-1 medications.
Additionally, GLP-1 medications require a prescription from a licensed healthcare professional, so products marketed as “GLP-1” without a prescription are not equivalent to FDA-approved GLP-1 medications.
If you’ve been searching for things like “do glp 1 patches work,” “glp 1 patches reviews,” or “glp1 patches reviews,” it’s important to understand that these over-the-counter products are not the same as prescription GLP-1 drugs.
{{primary-cta}}
Risks of GLP Patches
While prescribed GLP-1 medications have their benefits for specific populations, GLP patches carry several risks. Remember, most over-the-counter GLP-1 patches do not contain any GLP-1 medication, so they’re not expected to deliver the same effects as prescription-only GLP-1 drugs. On top of this, risks may include:
No FDA-Approval for Safety or Effectiveness
Unlike prescription GLP-1 drugs, which undergo rigorous testing, these patches are sold as supplements and are not reviewed by the FDA for effectiveness before being marketed, and quality may vary by the product.
Unproven Absorption Through the Skin
Many of the ingredients in GLP patches have primarily been studied when taken orally. In fact, there’s limited evidence indicating that these ingredients have the same benefits when penetrating the skin.
Potential Skin Reactions
When wearing an adhesive patch for a long duration, skin irritation may occur. And because these products aren’t required to undergo the same pre-market testing as prescription drugs, they may carry the risk of skin issues or reactions, and product quality and ingredients can vary between manufacturers.
Cardiovascular Concerns
Herbal ingredients, like synephrine, which may be included in some GLP-1 patches, come with their own set of risks. Research shows that synephrine has been associated with adverse cardiovascular effects.
Delayed Access to Effective Treatment
Using unproven patches may delay an individual’s decision to seek out proven and effective treatment methods, such as FDA-approved GLP-1 medications.
{{primary-cta}}
GLP-1 Patch Alternatives
Ultimately, GLP-1 medications must be prescribed by a licensed healthcare provider. Your doctor will ultimately recommend what’s best for you and your specific situation. Prescription GLP-1 patch alternatives include:
Semaglutide
Semaglutide is an FDA-approved GLP-1 receptor agonist available as a weekly injection—under the brand names Ozempic® and Wegovy®—or as a daily oral tablet—sold as Rybelsus®.
Ozempic® and Rybelsus® are approved for the management of type 2 diabetes, and Wegovy® is approved for chronic weight management in adults with obesity who meet certain criteria. Like other GLP-1 medications, semaglutide can cause side effects such as gastrointestinal symptoms and potentially serious risks described in its prescribing information, so it should only be used under the guidance of a licensed healthcare provider.
Liraglutide
Liraglutide is another FDA-approved GLP-1 receptor agonist, available only as a daily injection and under the brand names Victoza® and Saxenda®. Unlike the weekly dosing of some other GLP-1 medications, liraglutide is administered once per day.
Victoza® is approved for managing type 2 diabetes, while Saxenda® is approved for chronic weight management. Liraglutide can cause side effects, including nausea, vomiting, and potential serious risks such as pancreatitis and gallbladder problems, and is not right for everyone.
Tirzepatide
Tirzepatide is a newer medication that works as a dual GIP/GLP-1 receptor agonist, targeting two hormones involved in appetite and blood sugar regulation. It’s administered as a once-weekly injection.
Tirzepatide is sold under the two brand names, Mounjaro® and Zepbound®. Mounjaro® is approved for the management of type 2 diabetes, and Zepbound® is approved for chronic weight management in adults with obesity or overweight and weight-related conditions.
As a prescription-only medication manufactured under strict FDA oversight, tirzepatide has undergone safety and efficacy review that over-the-counter patches have not. A licensed healthcare provider can help determine if tirzepatide is right for you. These medications also carry important risks (including gastrointestinal side effects and a boxed warning about thyroid C-cell tumors) that should be discussed with your clinician.
Dulaglutide
Dulaglutide is a once-weekly injectable GLP-1 receptor agonist approved for the treatment of type 2 diabetes.
Sold under the brand name Trulicity®, it’s delivered through a single-use pen designed to provide consistent, accurate dosing. Dulaglutide can also cause side effects, including gastrointestinal symptoms and a boxed warning regarding thyroid C-cell tumors, and should only be used under the guidance of a licensed healthcare provider.
Final Thoughts
Before starting any new supplements or medication, it’s a good idea to discuss your options with your doctor; they know you and your health situation the best and can make personalized recommendations.
At the end of the day, GLP-1 patches are not FDA-approved GLP-1 medications. FDA-approved GLP-1 drugs require a prescription from a qualified healthcare professional. They are also strictly regulated and undergo various testing procedures to evaluate their safety and effectiveness before approval.
Simply put, most GLP 1 patches marketed as supplements don’t go through the same FDA pre-market review process and don’t contain the same active ingredients as prescription GLP-1 drugs. This is why it’s best to discuss your options with your doctor to ensure you make real and effective progress toward your health and wellness goals.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Eden is not a medical provider. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by state-licensed pharmacies. Please consult a licensed healthcare provider before making any medical decisions.
Frequently asked questions
Ozempic® is an FDA-approved prescription injection containing semaglutide, an FDA-approved GLP-1 receptor agonist medication. GLP-1 patches are typically marketed as dietary supplements containing herbal extracts and vitamins—not actual GLP-1 medication.
Prescription GLP-1 injections deliver medication directly into your bloodstream at therapeutic levels and are backed by clinical research. GLP-1 patches have limited evidence for effective skin absorption or clinically meaningful weight loss outcomes. Like all prescription medications, GLP-1 injections can cause side effects and are not appropriate for everyone, so treatment decisions should be made with a licensed healthcare provider.
Blog Components

References
de Jonge, M. L. L., Kieviet, L. C., Sierts, M., Egberink, L. B., & van der Heyden, M. A. G. (2023). Review of Case Reports on Adverse Events Related to Pre-workout Supplements Containing Synephrine. Cardiovascular toxicology, 23(1), 1–9. https://doi.org/10.1007/s12012-022-09777-z
Prescribing Information | RYBELSUS® (semaglutide) tablets 7 mg or 14 mg. (n.d.). https://www.rybelsus.com/prescribing-information.html
WEGOVY. (2017). WEGOVY (semaglutide) injection, for subcutaneous use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
OZEMPIC. (2023). Highlights of prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209637s020s021lbl.pdf
Novo Nordisk Inc. (2010). VICTOZA. https://www.novo-pi.com/victoza.pdf#guide
Novo Nordisk Inc. (2010). SAXENDA. https://www.novo-pi.com/saxenda.pdf#guide
MOUNJARO. (2022). Highlights of prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
ZEPBOUND. (2022). Highlights of prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217806s003lbl.pdf
TRULICITY. (2014). Highlights of prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125469s036lbl.pdf
The wellness insight you need, without the noise.


















